Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zingiber Officinale Patch for Acne Vulgaris
NCT06787222Phase 3Active, not recruiting
- Sponsor
- Hasanuddin University
- Start
- Nov 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Zingiber officinale 5% transdermal patch in acne vulgaris (2 arms), sponsored by Hasanuddin University. Primary endpoint: Total inflammatory acne lesions at 3 weeks. Started Nov 2024; status: active, not recruiting.
02
Drugs
Zingiber officinale 5% transdermal patch
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT06787222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06787222.